News
Latest news
27.02.2024
– Press release
Artiria Medical secures funding to complete its clinical studies in stroke in both Europe and the US following promising first in-human results and FDA clearance.
Artiria Medical secures funding to complete its clinical studies in stroke in both Europe and the US following promising first in-human results and FDA clearance.
26.05.2023
– Press release
Artiria receives FDA 510(k) clearance for Disruptive Deflectable Guidewire
Artiria Medical, a Swiss neurovascular MedTech company, announces that its real-time deflectable guidewire has been granted the 510(k) clearance by the U.S. Food and Drug Administration (FDA).